Business meeting to consider S.1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, S.3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, S.4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, S.2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, S.4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, S.2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, S.3014, to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions, and S.1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Inferred from the date. No official record confirms this meeting took place.
Video
Other votes this committee recorded that day(7)
These votes are recorded against this committee on the same date. The official sources do not say which meeting each was taken at, so they are listed separately rather than attributed to this one.
S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute
Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.
S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment
Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.
S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute
Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.
S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute
Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.
S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute
Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.
S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute
Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.
S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute
Committee ordered favorably reported the following business items: S. 1782, to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, with an amendment in the nature of a substitute; S. 3799, to amend the Public Health Service Act to reauthorize the Healthy Start Initiative, with an amendment; S. 4109, to reauthorize the Stem Cell Therapeutic and Research Act of 2005, with an amendment in the nature of a substitute; S. 2339, to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, with an amendment in the nature of a substitute; S. 4472, to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, with an amendment in the nature of a substitute; S. 2658, to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office, with an amendment in the nature of a substitute; and S. 1954, to improve the requirements for making a determination of interchangeability of a biological product and its reference product, with an amendment in the nature of a substitute.